Sunday, June 26, 2022
154,225FansLike
654,155FollowersFollow
0SubscribersSubscribe

Covaxin: Delhi HC refuses to stay order allowing Phase II, III trials on 2 to 18 year olds

The court issued notice to the Centre and Bharat Biotech to file their reply on a PIL against Covaxin's clinical trials for age group 2 to 18.

Want create site? Find Free WordPress Themes and plugins.

The Delhi High Court has refused to stay the Centre’s notification which has accorded permission to conduct the Phase II/III clinical trial of Covaxin in the age group 2 to 18 years to its manufacturer Bharat Biotech Ltd.

However, the court issued notice to the Centre and Bharat Biotech to file their reply on a PIL against Covaxin’s clinical trials for age group 2 to 18.

Read Also: Appeal against IGST on oxygen concentrator gifts from abroad for personal use: Delhi HC reserves order

Source: ILNS

Did you find apk for android? You can find new Free Android Games and apps.
spot_img

News Update